Times Square Capital Management, LLC Intra Cellular Therapies, Inc. Transaction History

Times Square Capital Management, LLC

$6.49 Billion
Q3 2024

A detailed history of Times Square Capital Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Times Square Capital Management, LLC holds 438,083 shares of ITCI stock, worth $36.5 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

438,083

Previous 411,483 6.46%

Holding current value

$36.5 Million

Previous $28.2 Million 13.66%

% of portfolio

0.49%

Previous 0.45%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$67.99 - $80.84 $1.81 Million - $2.15 Million	26,600 Added 6.46%	438,083 $32 Million
Q2 2024 Aug 08, 2024	BUY	$64.76 - $79.84 $1.83 Million - $2.26 Million	28,272 Added 7.38%	411,483 $28.2 Million
Q1 2024 May 07, 2024	SELL	$64.37 - $75.65 $7.28 Million - $8.56 Million	-113,139 Reduced 22.79%	383,211 $26.5 Million
Q4 2023 Feb 07, 2024	SELL	$46.37 - $73.65 $244,601 - $388,503	-5,275 Reduced 1.05%	496,350 $35.5 Million
Q3 2023 Nov 17, 2023	BUY	$52.09 - $64.1 $2.51 Million - $3.09 Million	48,250 Added 10.64%	501,625 $26.1 Million
Q2 2023 Aug 09, 2023	SELL	$54.67 - $66.44 $3.15 Million - $3.83 Million	-57,700 Reduced 11.29%	453,375 $28.7 Million
Q1 2023 May 10, 2023	SELL	$43.8 - $56.99 $8.63 Million - $11.2 Million	-196,925 Reduced 27.81%	511,075 $27.7 Million
Q4 2022 Feb 10, 2023	SELL	$44.07 - $54.45 $7.82 Million - $9.67 Million	-177,510 Reduced 20.05%	708,000 $37.5 Million
Q3 2022 Nov 09, 2022	BUY	$42.7 - $59.99 $3.62 Million - $5.08 Million	84,672 Added 10.57%	885,510 $41.2 Million
Q2 2022 Aug 05, 2022	SELL	$43.0 - $65.64 $3.28 Million - $5 Million	-76,190 Reduced 8.69%	800,838 $45.7 Million
Q1 2022 May 06, 2022	SELL	$38.74 - $62.09 $18.1 Million - $29 Million	-466,937 Reduced 34.74%	877,028 $53.7 Million
Q4 2021 Feb 04, 2022	SELL	$35.2 - $53.42 $13.2 Million - $20 Million	-374,700 Reduced 21.8%	1,343,965 $70.3 Million
Q3 2021 Nov 08, 2021	BUY	$28.72 - $42.49 $16.2 Million - $24 Million	565,285 Added 49.01%	1,718,665 $64.1 Million
Q2 2021 Aug 09, 2021	SELL	$29.3 - $44.5 $2.17 Million - $3.29 Million	-73,900 Reduced 6.02%	1,153,380 $47.1 Million
Q1 2021 May 12, 2021	BUY	$30.8 - $39.51 $10.4 Million - $13.4 Million	338,080 Added 38.02%	1,227,280 $41.6 Million
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $310,422 - $428,526	-13,300 Reduced 1.47%	889,200 $28.3 Million
Q3 2020 Nov 06, 2020	BUY	$17.61 - $31.86 $15.9 Million - $28.8 Million	902,500 New	902,500 $23.2 Million

Others Institutions Holding ITCI

# of Institutions

379

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.87B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Account

Times Square Capital Management, LLC Intra Cellular Therapies, Inc. Transaction History